Search research articles
Contact Us
Filters
Showing results (761-770 of 954) with videos related to
Page
of 96
Sort By:
Bipolar Disorders
|
July 3, 2026
Risk of Major Malformations Following First-Trimester Exposure to Cariprazine: Preliminary Data From the MGH National Pregnancy Registry for Psychiatric Medications
Adele C Viguera, Marlene P Freeman, Ella K Slaby, et al.
Mindfulness
|
August 14, 2018
Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of Ecstasy
Sunjeev K Kamboj, Ylva S E Walldén, Caroline J Falconer, et al.
Critical Care Medicine
|
December 1, 1989
Macromolecules reduce abnormal microvascular permeability in rat limb ischemia-reperfusion injury
B A Zikria, C Subbarao, M C Oz, et al.
Journal of Eating Disorders
|
January 7, 2021
An open trial of app-assisted acceptance and commitment therapy (iACT) for eating disorders in type 1 diabetes
Rhonda M Merwin, Ashley A Moskovich, Michael Babyak, et al.
Experimental and Clinical Psychopharmacology
|
June 21, 2019
Changes in the composition of cannabis from 2000-2017 in Denmark: Analysis of confiscated samples of cannabis resin
Kristine Rømer Thomsen, Christian Lindholst, Birgitte Thylstrup, et al.
Pharmacoepidemiology and Drug Safety
|
August 14, 2012
Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury
Charles E Leonard, Cristin P Freeman, Craig W Newcomb, et al.
Journal of Clinical Psychopharmacology
|
May 26, 2023
Risk of Major Malformations in Infants After First-Trimester Exposure to Stimulants: Results From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications
Mercedes J Szpunar, Marlene P Freeman, Lauren A Kobylski, et al.
Journal of Clinical Psychopharmacology
|
February 24, 2023
Risk of Major Malformations Following First-Trimester Exposure to Olanzapine: Preliminary Data From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications
Adele C Viguera, Marlene P Freeman, Lauren A Kobylski, et al.
Psychological Medicine
|
December 2, 2024
Associations of cannabis use, tobacco use, and incident anxiety, mood, and psychotic disorders: a systematic review and meta-analysis
Chloe Burke, Tom P Freeman, Hannah Sallis, et al.
The Journal of Clinical Psychiatry
|
September 27, 2019
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY)
Maurizio Fava, Bryan Dirks, Marlene P Freeman, et al.
Page
of 96
Search research articles
Search
Showing results (761-770 of 954) with videos related to
Sort By:
Page
of 96
Bipolar Disorders
|
July 3, 2026
Risk of Major Malformations Following First-Trimester Exposure to Cariprazine: Preliminary Data From the MGH National Pregnancy Registry for Psychiatric Medications
Adele C Viguera, Marlene P Freeman, Ella K Slaby, et al.
Mindfulness
|
August 14, 2018
Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of Ecstasy
Sunjeev K Kamboj, Ylva S E Walldén, Caroline J Falconer, et al.
Critical Care Medicine
|
December 1, 1989
Macromolecules reduce abnormal microvascular permeability in rat limb ischemia-reperfusion injury
B A Zikria, C Subbarao, M C Oz, et al.
Journal of Eating Disorders
|
January 7, 2021
An open trial of app-assisted acceptance and commitment therapy (iACT) for eating disorders in type 1 diabetes
Rhonda M Merwin, Ashley A Moskovich, Michael Babyak, et al.
Experimental and Clinical Psychopharmacology
|
June 21, 2019
Changes in the composition of cannabis from 2000-2017 in Denmark: Analysis of confiscated samples of cannabis resin
Kristine Rømer Thomsen, Christian Lindholst, Birgitte Thylstrup, et al.
Pharmacoepidemiology and Drug Safety
|
August 14, 2012
Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury
Charles E Leonard, Cristin P Freeman, Craig W Newcomb, et al.
Journal of Clinical Psychopharmacology
|
May 26, 2023
Risk of Major Malformations in Infants After First-Trimester Exposure to Stimulants: Results From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications
Mercedes J Szpunar, Marlene P Freeman, Lauren A Kobylski, et al.
Journal of Clinical Psychopharmacology
|
February 24, 2023
Risk of Major Malformations Following First-Trimester Exposure to Olanzapine: Preliminary Data From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications
Adele C Viguera, Marlene P Freeman, Lauren A Kobylski, et al.
Psychological Medicine
|
December 2, 2024
Associations of cannabis use, tobacco use, and incident anxiety, mood, and psychotic disorders: a systematic review and meta-analysis
Chloe Burke, Tom P Freeman, Hannah Sallis, et al.
The Journal of Clinical Psychiatry
|
September 27, 2019
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY)
Maurizio Fava, Bryan Dirks, Marlene P Freeman, et al.
Page
of 96